Enter: Semaglutide and Tirzepatide Over the last few years, medications like Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound) have changed the game for people struggling with weight loss including belly fat
Limited exceptions remain for patients with documented clinical needs, such as allergies to excipients in the commercial formulation
On February 7, 2024, Innovent announced that the New Drug Application (NDA) for mazdutide, a glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR) dual agonist, had been accepted by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China, for chronic weight management in adults with obesity or overweight
The FDA has posted notices for two nationwide dietary supplement recalls involving products found to contain undeclared pharmaceutical ingredients
Phase 3: Enhanced GLP-1 Sensitivity: Vitamin D3: Supports healthy metabolic function, helps maintain insulin sensitivity, and plays a role in appetite regulation and overall wellness
Medications such as opioids, ones affecting gastrointestinal motility, or anticholinergic agents will not particularly benefit from combining semaglutide with their current administration without prior advice from their healthcare providers 9 Potential non-responders : There might be certain individuals who might be afflicted with other underlying diseases, who might not respond accurately to semaglutide therapy
